Students listening to faculty presentations at the Mini Graduate School weekend program

The primary objective of the Genomics, Proteomics and Drug Discovery program is to train individuals with expertise to pursue an independent research career in the post-genomic era by adopting a multidisciplinary approach that integrate in theory and practice the principles of medicinal chemistry, molecular biology, genetics, structural biology, and computation. Students seek to understand the function of genes and proteins and use this knowledge for the discovery of novel chemical entities to modify a disease process by applying the latest technology in genomic, proteomic and chemical sciences, including genotyping, microarray, structural, synthetic, computational and combinatorial chemistry. Students use computational, biochemical and cell-based screening technologies to identify natural and synthetic compounds with pharmacological activity. Students also study structure-activity relationships to understand the mechanisms of drug action.

Primary Contact:
Yong Tae Kwon, PhD
Assistant Professor
645A Salk Hall
Pittsburgh, PA 15213
Phone: (412) 383-7994
Email: yok5@pitt.edu

Faculty Associated with this Focus Area
Curriculum for Genomics, Proteomics and Drug Discovery